{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T14:14:15Z","timestamp":1784470455269,"version":"3.55.0"},"reference-count":18,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T00:00:00Z","timestamp":1613520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Sugammadex provides a rapid pharmacological reversal of aminosteroid, as well as fewer pulmonary complications, a better physiological recovery, and shorter stays in the postanesthetic recovery unit (PACU). This retrospective analysis of our Centricity anesthesia database in 2017\u20132019 assessed the efficiency of sugammadex in real-life situations in two groups of surgical cancer patients (breast and abdominal surgery) based on the extubation time, operating room exit time, and length of PACU stay. Overall, 382 anesthesia records (131 breast and 251 abdominal surgeries) were extracted for the pharmacological reversal of neuromuscular blockades by neostigmine or sugammadex. Sugammadex was used for reversal in 91 breast and 204 abdominal surgeries. Sugammadex use did not affect the extubation time, operating room exit time, or length of PACU stay. However, the time to reach a 90% train of four (TOF) recovery was significantly faster in sugammadex patients: 2 min (1.5\u20138) in breast surgery and 2 min (1.5\u20137) in abdominal surgery versus 10 (6\u201320) and 9 min (5\u201320), respectively, for neostigmine (p &lt; 0.05). Most patients who were reversed with sugammadex (91%) reached a TOF ratio of at least 90%, while 54% of neostigmine patients had a 90% TOF ratio recorded (p &lt; 0.05). Factors other than pharmacological reversal probably influence the extubation time, operating room exit time, or PACU stay; however, sugammadex reliably shortened the time so as to reach a 90% TOF ratio with a better level of reversal.<\/jats:p>","DOI":"10.3390\/jcm10040815","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T21:35:42Z","timestamp":1613597742000},"page":"815","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Comparison of the Time to Extubation and Length of Stay in the PACU after Sugammadex and Neostigmine Use in Two Types of Surgery: A Monocentric Retrospective Analysis"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0298-9882","authenticated-orcid":false,"given":"Cyrus","family":"Motamed","sequence":"first","affiliation":[{"name":"Department of Anesthesia, Institut Gustave Roussy, 94080 Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Louis","family":"Bourgain","sequence":"additional","affiliation":[{"name":"Department of Anesthesia, Institut Gustave Roussy, 94080 Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,2,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jcrc.2008.08.004","article-title":"Neuromuscular transmission: New concepts and agents","volume":"24","year":"2009","journal-title":"J. Crit. Care"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.bja.2018.07.014","article-title":"Sugammadex: The sting in the tail?","volume":"121","author":"Savic","year":"2018","journal-title":"Br. J. Anaesth."},{"key":"ref_3","first-page":"CD012763","article-title":"Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults","volume":"8","author":"Hristovska","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/anae.14160","article-title":"The comparative efficacy and safety of sugammadex and neostigmine in reversing neuromuscular blockade in adults. A Cochrane systematic review with meta-analysis and trial sequential analysis","volume":"73","author":"Hristovska","year":"2018","journal-title":"Anaesthesia"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/ALN.0b013e31818a3fee","article-title":"Reversal of profound rocuronium-induced blockade with sugammadex: A randomized comparison with neostigmine","volume":"109","author":"Jones","year":"2008","journal-title":"Anesthesiology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1007\/s11695-013-0926-y","article-title":"Sugammadex allows fast-track bariatric surgery","volume":"23","author":"Carron","year":"2013","journal-title":"Obes. Surg."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jclinane.2017.03.004","article-title":"Role of sugammadex in accelerating postoperative discharge: A meta-analysis","volume":"39","author":"Carron","year":"2017","journal-title":"J. Clin. Anesth."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"109804","DOI":"10.1016\/j.jclinane.2020.109804","article-title":"Sugammadex versus neostigmine for reversal of rocuronium-induced neuromuscular blockade: A randomized, double-blinded study of thoracic surgical patients evaluating hypoxic episodes in the early postoperative period","volume":"64","author":"Moon","year":"2020","journal-title":"J. Clin. Anesth."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.accpm.2015.11.002","article-title":"An anaesthesia information management system as a tool for a quality assurance program: 10 years of experience","volume":"35","author":"Motamed","year":"2016","journal-title":"Anaesth. Crit. Care Pain Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s10877-013-9491-0","article-title":"Survey of muscle relaxant effects management with a kinemyographic-based data archiving system: A retrospective quantitative and contextual quality control approach","volume":"27","author":"Motamed","year":"2013","journal-title":"J. Clin. Monit. Comput."},{"key":"ref_11","first-page":"125","article-title":"Guidelines on muscle relaxants and reversal in anaesthesia. Anaesth","volume":"39","author":"Plaud","year":"2020","journal-title":"Crit. Care Pain Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/EJA.0000000000000585","article-title":"Impact of reversal strategies on the incidence of postoperative residual paralysis after rocuronium relaxation without neuromuscular monitoring: A partially randomised placebo controlled trial","volume":"34","author":"Nemes","year":"2017","journal-title":"Eur. J. Anaesthesiol."},{"key":"ref_13","first-page":"55","article-title":"Neuromuscular monitoring: An update. Rom","volume":"25","author":"Dutu","year":"2018","journal-title":"J. Anaesth. Intensive Care"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jclinane.2019.02.014","article-title":"Influence of reversal of neuromuscular blockade with sugammadex or neostigmine on postoperative quality of recovery following a single bolus dose of rocuronium: A prospective, randomized, double-blinded, controlled study","volume":"57","author":"Kim","year":"2019","journal-title":"J. Clin. Anesth."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1097\/ALN.0000000000003575","article-title":"Pulmonary outcomes and sugammadex versus neostigmine: Reply","volume":"133","author":"Kheterpal","year":"2020","journal-title":"Anesthesiology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1097\/ALN.0000000000003256","article-title":"Sugammadex versus neostigmine for reversal of neuromuscular blockade and postoperative pulmonary complications (STRONGER): A multicenter matched cohort analysis","volume":"132","author":"Kheterpal","year":"2020","journal-title":"Anesthesiology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s40140-018-0265-6","article-title":"Sugammadex: Appropriate use in the context of budgetary constraints","volume":"8","author":"Cammu","year":"2018","journal-title":"Curr. Anesthesiol. Rep."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Domenech, G., Kampel, M.A., Garcia Guzzo, M.E., Novas, D.S., Terrasa, S.A., and Fornari, G.G. (2019). Usefulness of intra-operative neuromuscular blockade monitoring and reversal agents for postoperative residual neuromuscular blockade: A retrospective observational study. BMC Anesthesiol., 19.","DOI":"10.1186\/s12871-019-0817-4"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/4\/815\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:25:20Z","timestamp":1760160320000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/4\/815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,17]]},"references-count":18,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,2]]}},"alternative-id":["jcm10040815"],"URL":"https:\/\/doi.org\/10.3390\/jcm10040815","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,17]]}}}